Autoimmune hemolytic anemia and classical Hodgkin lymphoma: A case report and literature review

Clinical Advances in Hematology and Oncology

Volumn 10, Issue 4, 2012, Pages 270-276

  Feng, Qi ^a   Zak, Dmitry ^a   Daya, Rami ^a  

^a LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BILIRUBIN; BLEOMYCIN; CHLORMETHINE; CISPLATIN; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FERRITIN; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; STEROID; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BIOPSY; CACHEXIA; CASE REPORT; CHILL; CLASSICAL HODGKIN LYMPHOMA; COMPUTER ASSISTED TOMOGRAPHY; COOMBS TEST; DECREASED APPETITE; ERYTHROCYTE TRANSFUSION; FLANK PAIN; HEPATOMEGALY; HUMAN; HUMAN TISSUE; JAUNDICE; LYMPHADENOPATHY; LYMPHOCYTE DEPLETION HODGKIN LYMPHOMA; LYMPHOCYTE-RICH CLASSICAL HODGKIN LYMPHOMA; MALE; MIXED CELLULARITY HODGKIN LYMPHOMA; MULTIPLE CYCLE TREATMENT; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NORMOCHROMIC NORMOCYTIC ANEMIA; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; RETICULOCYTE COUNT; SPLENECTOMY; SWEAT; WEIGHT REDUCTION;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; ERYTHROCYTE TRANSFUSION; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PREDNISONE; VINBLASTINE;

EID: 84859638801     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Xiros N, Binder T, Anger B, Böhlke J, Heimpel H. Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin's disease. Eur J Haematol. 1988;40:437-441.
2. Andrieu JM, Youinou P, Marcelli A. Autoimmune haemolytic anaemia associated with Hodgkin's disease. Characteristics, prognosis and incidence (author's transl). Nouv Presse Med. 1981;10:2951-2954.
3. Levine AM, Thornton P, Forman SJ, et al. Positive Coombs test in Hodgkin's disease: significance and implications. Blood. 1980;55:607-611.
4. Lechner K, Chen YA. Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma. Leuk Lymphoma. 2010;51:469-474.
5. Engelfriet CP, Overbeeke MA, von dem Borne AE. Autoimmune hemolytic anemia. Semin Hematol. 1992;29:3-12.
6. Garratty G, Petz LD, Wallerstein RO, Fudenberg HH. Autoimmune hemolytic anemia in Hodgkin's disease associated with anti-IT. Transfusion. 1974;14:226-231.
7. Shah SJ, Warrier RP, Ode DL, Lele HE, Yu LC. Immune thrombocytopenia and hemolytic anemia associated with Hodgkin disease. J Pediatr Hematol Oncol. 1996;18:227-229.
8. Cozen W, Katz J, Mack TM. Risk patterns of Hodgkin's disease in Los Angeles vary by cell type. Cancer Epidemiol Biomarkers Prev. 1992;1:261-268.
9. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 24-1978. N Engl J Med. 1978;298:1407-1412.
10. Björkholm M, Holm G, Merk K. Cyclic autoimmune hemolytic anemia as a presenting manifestation of splenic Hodgkin's disease. Cancer. 1982;49:1702-1704.
11. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-1997. A 32-year-old man with IgG antibody and Coombs'-positive hemolytic anemia resistant to corticosteroid therapy. N Engl J Med. 1997;336:1235-1241.
12. Eisner E, Ley AB, Mayer K. Coombs'-positive hemolytic anemia in Hodgkin's disease. Ann Intern Med. 1967;66:258-273.
13. Chu JY. Autoimmune hemolytic anemia in childhood Hodgkin's disease. Am J Pediatr Hematol Oncol. 1982;4:125-128.
14. Majumdar G. Unremitting severe autoimmune haemolytic anaemia as a presenting feature of Hodgkin's disease with minimum tumour load. Leuk Lymphoma. 1995;20:169-172.
15. Siddiqui N, Aleem A. Autoimmune haemolytic anaemia preceding the diagnosis of Hodgkin's disease: a report of two cases and review of the literature. J Pak Med Assoc. 2009;59:316-319.
16. Sierra RD. Coombs-positive hemolytic anemia in Hodgkin's disease: case presentation and review of the literature. Mil Med. 1991;156:691-692.
17. Ozdemir F, Yilmaz M, Akdogan R, et al. Hodgkin's disease and autoimmune hemolytic anemia: a case report. Med Princ Pract. 2005;14:205-207.
18. Surveillance Epidemiology and End Results (SEER) Website. SEER Stat Fact Sheets: Hodgkin Lymphoma. http://seer.cancer.gov/statfacts/html/hodg.html. Accessed February 8, 2012.
19. Bauduer F. Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma. Br J Haematol. 2001;112:1085-1086.
20. Zaja F, Iacona I, Masolini P, et al. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica. 2002;87:189-195.
21. Silvana B, Antonella LM, Basilia P, Trombetta D, Saija A, Salpietro C. Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome. Pediatr Transplant. 2007;11:552-556.
22. Schulz H, Rehwald U, Morschhauser F, et al. Rituximab in relapsed lymphocyte- predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG). Blood. 2007;111:109-111.
23. Avivi I, Robinson S, Goldstone A. Clinical use of rituximab in haematological malignancies. Br J Cancer. 2003;89:1389-1394.
24. Jackson C, Sirohi B, Cunningham D, Horwich A, Thomas K, Wotherspoon A. Lymphocyte-predominant Hodgkin Lymphoma-clinical features and treatment outcomes from a 30-years experience. Ann Onc. 2010;21:2061-2068.
25. Younes A, Romaguera J, Hagemeister F, et al. A pilot study of rituximab in patients with recurrent, classic Hodgkin disease. Cancer. 2003;98:310-314.
26. Saini KS, Azim HA Jr, Cocorocchio E, et al. Rituximab in Hodgkin lymphoma: is the target always a hit? Cancer Treat Rev. 2011;37:385-390. Epub 2010 Dec 22.
27. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998;339:1506-1514.
28. Bowdler AJ, Glick IW. Autoimmune hemolytic anemia as the herald state of Hodgkin's disease. Ann Intern Med. 1966;65:761-767.
29. Cazenave JP, Gagnon JA, Girouard E, Bastarache A. Autoimmune hemolytic anemia terminating seven years later in Hodgkin's disease. Can Med Assoc J. 1973;109:748-749.
30. Jones SE. Autoimmune disorders and malignant lymphoma. Cancer. 1973;31:1092-1098.
31. May RB, Bryan JH. Autoimmune hemolytic anemia and Hodgkin disease. J Pediatr. 1976;89:428-429.
32. Chu JY, McElfresh AE, Waeltermann RM. Autoimmune hemolytic anemia as a presenting manifestation of Hodgkin disease. J Pediatr. 1976;89:429-430.
33. Carpentieri U, Daeschner CW 3rd, Haggard ME. Immunohemolytic anemia and Hodgkin disease. Pediatrics. 1982;70:320-321.
34. Kalmanti M, Polychronopoulou S. Autoimmune hemolytic anemia as an initial symptom in children Hodgkin's disease. Pediatr Hematol Oncol. 1992;9:393-395.
35. Pasini S, Pasini G, Candoli P, Guardigni L. Hodgkin's disease presenting as hemolytic anemia. Haematologica. 1992;77:95.
36. Costello RT, Xerri L, Bouabdallah R, Gastaut JA, Sainty D. Leukopenia, thrombocytopenia, and acute autoimmune hemolytic anemia associated with an unusual (type 2/4) Hodgkin's disease: case report. Am J Hematol. 1996;52:333-334.
37. Brady-West DC, Thame J, West W. Autoimmune haemolytic anaemia, immune thrombocytopenia, and leucopenia. An unusual presentation of Hodgkin's disease. West Indian Med J. 1997;46:95-96.
38. Kondo H, Oyamada T, Mori A, et al. Direct-antiglobulin-test-negative immune haemolytic anaemia and thrombocytopenia in a patient with Hodgkin's disease. Acta Haematol. 2001;105:233-236.